ALC
Alcon Inc. NYSE$74.09
Mkt Cap $36.8B
52w Low $71.55
9.2% of range
52w High $99.20
50d MA $78.69
200d MA $79.45
P/E (TTM)
37.2x
EV/EBITDA
18.2x
P/B
1.7x
Debt/Equity
0.2x
ROE
-14.8%
P/FCF
22.6x
RSI (14)
—
ATR (14)
—
Beta
0.74
50d MA
$78.69
200d MA
$79.45
Avg Volume
1.6M
About
Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custo…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | AMC | 0.79 | 0.78 | -1.3% | 84.13 | +1.3% | +2.5% | +3.1% | +3.6% | +0.7% | -1.2% | -11.5% | — |
| Nov 11, 2025 | AMC | 0.77 | 0.79 | +2.6% | 77.36 | +5.2% | +2.7% | +1.6% | +0.4% | -1.0% | -2.0% | +1.8% | — |
| Aug 19, 2025 | AMC | 0.71 | 0.76 | +7.0% | 90.12 | -8.7% | -10.1% | -12.1% | -9.0% | -10.4% | -9.6% | -13.7% | — |
| May 13, 2025 | AMC | 0.76 | 0.73 | -3.9% | 93.25 | -5.7% | -6.4% | -6.0% | -3.7% | -4.2% | -5.6% | -4.4% | — |
| Feb 25, 2025 | AMC | 0.70 | 0.72 | +2.9% | 91.11 | +3.5% | +2.4% | +0.9% | +1.5% | +3.3% | +1.6% | +6.2% | — |
| Nov 12, 2024 | AMC | 0.72 | 0.81 | +12.5% | 86.89 | -0.8% | +0.7% | -2.0% | -2.0% | -1.2% | -1.7% | -1.3% | — |
| Aug 20, 2024 | AMC | 0.74 | 0.74 | +0.0% | 96.50 | -2.7% | -1.9% | -1.2% | -0.4% | -1.3% | -0.5% | +1.9% | — |
| May 13, 2024 | AMC | 0.72 | 0.78 | +8.3% | 80.92 | +9.6% | +10.3% | +11.2% | +10.1% | +9.8% | +8.9% | +14.0% | — |
| Feb 27, 2024 | AMC | 0.68 | 0.69 | +1.5% | 81.18 | +4.1% | +5.6% | +4.2% | +6.8% | +5.8% | +4.7% | +2.6% | — |
| Nov 14, 2023 | AMC | 0.67 | 0.66 | -1.5% | 74.96 | -5.1% | -5.9% | -7.2% | -5.9% | -5.0% | -3.5% | +2.8% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 | BTIG | Maintains | Buy → Buy | — | $73.65 | $74.55 | +1.2% | +0.7% | +0.8% | +2.2% | +1.1% | -0.4% |
| Mar 9 | Stifel | Maintains | Hold → Hold | — | $81.33 | $80.05 | -1.6% | +0.6% | -0.8% | -0.7% | -3.5% | -4.9% |
| Feb 26 | Needham | Maintains | Buy → Buy | — | $86.27 | $87.55 | +1.5% | +0.5% | +1.1% | -1.8% | -3.7% | -2.3% |
| Feb 26 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $86.27 | $87.55 | +1.5% | +0.5% | +1.1% | -1.8% | -3.7% | -2.3% |
| Feb 26 | Barclays | Maintains | Equal Weight → Equal Weight | — | $86.27 | $87.55 | +1.5% | +0.5% | +1.1% | -1.8% | -3.7% | -2.3% |
| Feb 25 | BTIG | Maintains | Buy → Buy | — | $84.13 | $85.24 | +1.3% | +2.5% | +3.1% | +3.6% | +0.7% | -1.2% |
| Jan 9 | Stifel | Downgrade | Buy → Hold | — | $80.62 | $80.35 | -0.3% | -0.6% | +0.3% | -2.0% | -0.6% | -1.2% |
| Dec 11 | BofA Securities | Downgrade | Buy → Underperform | — | $80.21 | $79.74 | -0.6% | -1.8% | -1.8% | -1.3% | -1.5% | -1.2% |
| Nov 24 | BTIG | Maintains | Buy → Buy | — | $76.61 | $76.31 | -0.4% | -0.5% | +4.0% | +3.3% | +3.5% | +2.1% |
| Nov 13 | Baird | Maintains | Outperform → Outperform | — | $79.44 | $79.25 | -0.2% | -1.0% | -2.3% | -3.6% | -4.6% | -5.1% |
Data updated apr 24, 2026 5:08pm
· Source: massive.com